M A Wainberg

AIDS research funding in Canada: future directions and government policy.

M T Schechter, M A Wainberg, 1991, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

HIV-1 reverse transcription: a brief overview focused on structure-function relationships among molecules involved in initiation of the reaction.

M A Wainberg, M. Wainberg, X. Li, 1999, Archives of biochemistry and biophysics.

The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection

M A Wainberg, M. Wainberg, R. Geleziunas, 1995, Microbiological reviews.

Identification of a novel glucocorticoid response element within the genome of the human immunodeficiency virus type 1.

M A Wainberg, M. Wainberg, J. Hiscott, 1993, Virology.

Identification of novel mutations that confer drug resistance in the human immunodeficiency virus polymerase gene.

M A Wainberg, M. Wainberg, B. Brenner, 1994, Leukemia.

Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine

M A Wainberg, M. Wainberg, Q. Gao, 1992, Journal of virology.

The role and fate of the CD4 molecule in lymphocytes and monocytes infected by HIV-1.

M A Wainberg, S Bour, R Geleziunas, 1993, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use

M A Wainberg, M. Wainberg, B. Brenner, 2000, AIDS.

Regulation of Human Immunodeficiency Virus Type 1 and Cytokine Gene Expression in Myeloid Cells by Nf-␬b/rel Transcription Factors

M A Wainberg, M. Wainberg, J. Hiscott, 2022 .

Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine

M A Wainberg, M. Wainberg, H. Salomón, 1994, Antimicrobial Agents and Chemotherapy.